ISPECIMEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.309 USD | -1.87% |
|
-17.73% | -38.27% |
| 06-03 | Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May | MT |
| 06-03 | Top Premarket Decliners | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 68.07 | 12.26 | 4.543 | 4.031 | - | - |
| Enterprise Value (EV) 1 | 68.07 | 12.26 | 4.543 | 4.031 | 4.031 | 4.031 |
| P/E ratio | -3.74 x | -1.19 x | -0.41 x | -0.27 x | -0.27 x | - |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 6.11 x | 1.18 x | 0.46 x | 0.35 x | 0.32 x | 0.28 x |
| EV / Revenue | 6.11 x | 1.18 x | 0.46 x | 0.35 x | 0.32 x | 0.28 x |
| EV / EBITDA | -13.8 x | -1.37 x | -0.5 x | -0.43 x | -0.4 x | - |
| EV / FCF | -5.85 x | -1.36 x | -0.43 x | -0.28 x | -0.26 x | -0.38 x |
| FCF Yield | -17.1% | -73.5% | -232% | -363% | -379% | -265% |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 8,716 | 8,918 | 9,076 | 13,044 | - | - |
| Reference price 2 | 7.810 | 1.375 | 0.5006 | 0.3090 | 0.3090 | 0.3090 |
| Announcement Date | 17/02/22 | 14/03/23 | 13/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 11.14 | 10.4 | 9.928 | 11.54 | 12.7 | 14.61 |
| EBITDA 1 | - | -4.921 | -8.981 | -9.054 | -9.457 | -10.15 | - |
| EBIT 1 | - | -5.925 | -10.19 | -11.17 | -12.08 | -13.58 | -9.494 |
| Operating Margin | - | -53.21% | -97.92% | -112.5% | -104.72% | -106.89% | -65% |
| Earnings before Tax (EBT) 1 | - | -8.962 | -10.25 | -11.1 | -11.96 | -13.54 | - |
| Net income 1 | -4.652 | -8.962 | -10.25 | -11.1 | -11.96 | -13.54 | - |
| Net margin | - | -80.48% | -98.5% | -111.8% | -103.67% | -106.57% | - |
| EPS 2 | -4.970 | -2.090 | -1.160 | -1.230 | -1.150 | -1.150 | - |
| Free Cash Flow 1 | - | -11.63 | -9.009 | -10.55 | -14.64 | -15.29 | -10.68 |
| FCF margin | - | -104.44% | -86.6% | -106.28% | -126.92% | -120.42% | -73.13% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 02/04/21 | 17/02/22 | 14/03/23 | 13/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2.549 | 2.519 | 2.339 | 2.583 | 2.962 | 2.95 | 1.625 | 2.778 | 2.575 | 2.29 | 2.881 | 2.892 | 2.92 |
| EBITDA 1 | -1.739 | -1.891 | -2.064 | -2.173 | -1.776 | -2.071 | -3.023 | -1.67 | -2.291 | -2.937 | -2.264 | -2.378 | -2.529 |
| EBIT 1 | -1.995 | -2.358 | -2.585 | -3.101 | -2.142 | -2.542 | -3.562 | -2.194 | -2.871 | -3.001 | -2.895 | -3.059 | -3.26 |
| Operating Margin | -78.26% | -93.64% | -110.53% | -120.04% | -72.31% | -86.18% | -219.17% | -78.99% | -111.49% | -131.03% | -100.49% | -105.77% | -111.64% |
| Earnings before Tax (EBT) 1 | -2.05 | -2.384 | -2.607 | -3.096 | -2.16 | -2.432 | -3.484 | -2.111 | -3.073 | -2.902 | -2.862 | -3.032 | -3.237 |
| Net income 1 | -2.05 | -2.384 | -2.607 | -3.096 | -2.16 | -2.432 | -3.484 | -2.111 | -3.073 | -2.902 | -2.862 | -3.032 | -3.237 |
| Net margin | -80.44% | -94.64% | -111.46% | -119.83% | -72.92% | -82.43% | -214.36% | -76% | -119.33% | -126.73% | -99.34% | -104.84% | -110.86% |
| EPS 2 | -0.2700 | -0.2700 | -0.3000 | -0.3500 | -0.2400 | -0.2700 | -0.3900 | -0.2300 | -0.3400 | -0.3200 | -0.2800 | -0.2900 | -0.3100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 17/02/22 | 10/05/22 | 04/08/22 | 08/11/22 | 14/03/23 | 04/05/23 | 02/08/23 | 02/11/23 | 13/03/24 | 07/05/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -11.6 | -9.01 | -10.6 | -14.6 | -15.3 | -10.7 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | - | 1.04 | 3.19 | 4.74 | 5.03 | 5.03 | 5.28 |
| Capex / Sales | - | 9.32% | 30.68% | 47.79% | 43.56% | 39.56% | 36.12% |
| Announcement Date | 02/04/21 | 17/02/22 | 14/03/23 | 13/03/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.309
USD
Average target price
3
USD
Spread / Average Target
+870.87%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.27% | 4.03M | |
| +18.86% | 3,322B | |
| +15.57% | 91.17B | |
| +12.99% | 84.37B | |
| +47.52% | 56.41B | |
| -20.20% | 49.69B | |
| +35.77% | 47.79B | |
| -25.64% | 46.04B | |
| +76.35% | 41.02B | |
| -3.39% | 27.21B |
- Stock Market
- Equities
- ISPC Stock
- Financials iSpecimen Inc.
